Thyroid nodules with GEA and low-risk mutations such as HRAS or NRAS are significantly more likely to be low-grade malignancies such as a follicular variant of papillary thyroid carcinoma. This evidence concerns the gene HRAS and thyroid gland papillary carcinoma.